EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

COVID‐19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity‐Matched Cohort Study

Usman Ali Akbar iD, Harshith Thyagaturu iD, Amro Taha iD, Lalitsiri Atti, Allahdad Khan iD, Sameer Raina, Sudarshan Balla iD

Journal of the American Heart Association · 04.11.2025 · 14 (21)

DOI: 10.1161/jaha.125.044546 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.11.2025. Verfasst von Usman Ali Akbar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine WVU Medicine - Camden Clark Medical Center Parkersburg WV USA. Hauptthemen laut MEDLINE: COVID-19, Heart Failure, COVID-19 Vaccines, Coronary Artery Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with coronary artery disease or heart failure (HF) face heightened COVID‐19 and cardiovascular risk, yet the long‐term cardiac effects of COVID‐19 vaccination in this population remain uncertain.

Methods

We performed a retrospective, propensity‐matched cohort study using the TriNetX US Collaborative Network (December 2020–December 2022). Adults with coronary artery disease or HF were matched 1:1, creating 74 236 vaccinated and 74 236 calendar‐aligned unvaccinated patients. Outcomes included mortality, acute myocardial infarction, stroke, HF hospitalization, deep vein thrombosis/pulmonary embolism, atrial fibrillation hospitalization, myocarditis, pericarditis, percutaneous coronary intervention, and coronary artery bypass grafting at 1‐year and 2‐year follow‐ups.

Results

Vaccination was associated with a dose‐dependent reduction in all‐cause mortality. Landmark hazard ratios (HRs) remained favorable, 0.92 (95% CI, 0.89–0.95), 0.99 (95% CI, 0.96–1.02), and 0.72 (95% CI, 0.70–0.74), confirming robustness across time periods. Vaccination was also associated with fewer HF hospitalizations (2‐year HR, 0.90 [95% CI, 0.87–0.94]) and lower revascularization rates (percutaneous coronary intervention HR, 0.87; coronary artery bypass grafting HR, 0.80), while showing no significant association with acute myocardial infarction, stroke, or venous thromboembolism. Although the study was underpowered to definitively assess rare safety events, a small increase in myocarditis was observed (2‐year HR, 1.36), representing a potential safety signal that warrants further investigation; pericarditis was not significantly elevated.

Conclusions

COVID‐19 vaccination was associated with a graded reduction in mortality that persisted after landmark adjustment, as well as lower rates of HF admissions and revascularizations. Findings support the use of complete vaccination, including boosters, as part of secondary prevention, pending confirmation in prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Heart FailureCOVID-19 VaccinesCoronary Artery DiseaseVaccinationHumansFemaleMaleRetrospective StudiesAgedPropensity ScoreMiddle AgedHospitalizationUnited StatesSARS-CoV-2Aged, 80 and over

Stichwörter der Autor:innen

COVID‐19 vaccinationcoronary artery diseasedose–responseheart failuremortality

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medicine WVU Medicine - Camden Clark Medical Center Parkersburg WV USA.
  • Department of Cardiology West Virginia University Morgantown WV USA.
  • Department of Internal Medicine Sparrow Hospital, Michigan State University Lansing MI USA.
  • Department of Medicine Nishtar Medical University Multan Pakistan.
  • Division of Cardiovascular Medicine, Stanford Cardiovascular Institute Stanford University Stanford CA USA.

ORCID-Profile: Usman Ali Akbar, Harshith Thyagaturu, Amro Taha, Allahdad Khan, Sudarshan Balla

Zitieren

APA

Akbar, U. A., Thyagaturu, H., Taha, A., Atti, L., Khan, A., Raina, S., & Balla, S. (2025). COVID‐19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity‐Matched Cohort Study. Journal of the American Heart Association, 14(21). https://doi.org/10.1161/jaha.125.044546

Vancouver

Akbar UA, Thyagaturu H, Taha A, Atti L, Khan A, Raina S, et al. COVID‐19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity‐Matched Cohort Study. Journal of the American Heart Association. 2025;14(21). doi:10.1161/jaha.125.044546

BibTeX
@article{Akbar2025,
  author = {Akbar, Usman Ali and Thyagaturu, Harshith and Taha, Amro and Atti, Lalitsiri and Khan, Allahdad and Raina, Sameer and Balla, Sudarshan},
  title = {COVID‐19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity‐Matched Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {21},
  doi = {10.1161/jaha.125.044546}
}
Kostenlos starten →